Black Rock Inc. Incyte Corp Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INCY
# of Institutions
695Shares Held
194MCall Options Held
564KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$2 Billion22.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.3 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$967 Million0.55% of portfolio
-
State Street Corp Boston, MA10MShares$653 Million0.03% of portfolio
-
Aqr Capital Management LLC Greenwich, CT6.74MShares$438 Million0.43% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $14.5B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...